127 related articles for article (PubMed ID: 7483354)
1. [Lipoprotein (a): a genetic risk factor with atherogenic and thrombogenic properties].
Vaverková H; Novotný D
Vnitr Lek; 1995 Sep; 41(9):618-23. PubMed ID: 7483354
[TBL] [Abstract][Full Text] [Related]
2. [Lipoprotein (a)--a mysterious factor in atherogenesis].
Jelaković B; Laganović M; Kuzmanić D
Lijec Vjesn; 2002; 124(11-12):366-71. PubMed ID: 12679978
[TBL] [Abstract][Full Text] [Related]
3. [Lipoprotein(a) as an athero-thrombotic risk factor: epidemiologic evidence and possible pathogenetic mechanisms].
Lenzi S; Scanu A; De Caterina R
G Ital Cardiol; 1996 Oct; 26(10):1203-25. PubMed ID: 9005165
[TBL] [Abstract][Full Text] [Related]
4. [Lipoprotein (a), a cardiovascular risk factor: importance of its determination in current clinical practice].
Couderc R; Maachi M
J Mal Vasc; 1998 Jun; 23(3):165-75. PubMed ID: 9669219
[TBL] [Abstract][Full Text] [Related]
5. [Lipoprotein(a): a link between thrombosis and atherosclerosis?].
Hansen PR
Ugeskr Laeger; 1993 May; 155(20):1527-30. PubMed ID: 8316983
[TBL] [Abstract][Full Text] [Related]
6. [Genetic aspects of high variability of lipoprotein(a) levels].
Zídková K; Zlatohlávek L; Ceska R
Cas Lek Cesk; 2007; 146(8):653-7. PubMed ID: 17874731
[TBL] [Abstract][Full Text] [Related]
7. [Hyperlipoprotein (a)-emia determined by genetic polymorphisms in apolipoprotein (a) gene].
Ichinose A
Brain Nerve; 2008 Nov; 60(11):1307-17. PubMed ID: 19069164
[TBL] [Abstract][Full Text] [Related]
8. [Role of lipoprotein (a) in the development of atherosclerosis and formation of thrombi].
Wandzilak M; Jodłowski J
Pol Tyg Lek; 1991 Sep 9-30; 46(37-39):720-1. PubMed ID: 1669142
[TBL] [Abstract][Full Text] [Related]
9. [Research progress in lipoprotein (a): aspects of biochemistry and molecular biology].
Huang YT
Sheng Li Ke Xue Jin Zhan; 1996 Jan; 27(1):25-30. PubMed ID: 8731979
[TBL] [Abstract][Full Text] [Related]
10. [Lipoprotein(a)--atherogenic waste product of evolution?].
Kronenberg F; Utermann G
Wien Med Wochenschr; 1994; 144(12-13):324-30. PubMed ID: 8650938
[TBL] [Abstract][Full Text] [Related]
11. [Lipoprotein(a): risk factor for atherosclerotic vascular disease important to take into account in practice].
Couderc R; Maachi M
Ann Biol Clin (Paris); 1999; 57(2):157-67. PubMed ID: 10210742
[TBL] [Abstract][Full Text] [Related]
12. Genetics and metabolism of lipoprotein(a) and their clinical implications (Part 1).
Dieplinger H; Kronenberg F
Wien Klin Wochenschr; 1999 Jan; 111(1):5-20. PubMed ID: 10067265
[TBL] [Abstract][Full Text] [Related]
13. Lipoprotein(a) as a risk factor for atherosclerosis and thrombosis: mechanistic insights from animal models.
Boffa MB; Marcovina SM; Koschinsky ML
Clin Biochem; 2004 May; 37(5):333-43. PubMed ID: 15087247
[TBL] [Abstract][Full Text] [Related]
14. [The significance of lipoprotein(a) in assessment of risk for atherosclerosis].
Kullich W; Machreich K
Wien Med Wochenschr; 1994; 144(17):407-11. PubMed ID: 7839688
[TBL] [Abstract][Full Text] [Related]
15. [Genetic predisposition for the multiple metabolic syndrome. Part 4. Apolipoprotein E and lipoprotein (a)].
Sobra J; Ceska R
Cas Lek Cesk; 1999 Mar; 138(7):203-8. PubMed ID: 10510535
[TBL] [Abstract][Full Text] [Related]
16. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
[TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
Petersen KR
Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein a polymorphism predicts lipoprotein a concentration in renal transplant recipients.
Argani H; Ghorbanihaghjo A; Rashtchizadeh N; Rahbaninobar M
Transplant Proc; 2005 Sep; 37(7):2925-8. PubMed ID: 16213263
[TBL] [Abstract][Full Text] [Related]
19. Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a).
Dieplinger H; Lackner C; Kronenberg F; Sandholzer C; Lhotta K; Hoppichler F; Graf H; König P
J Clin Invest; 1993 Feb; 91(2):397-401. PubMed ID: 8432847
[TBL] [Abstract][Full Text] [Related]
20. Structural basis for the pathophysiology of lipoprotein(a) in the athero-thrombotic process.
Anglés-Cano E
Braz J Med Biol Res; 1997 Nov; 30(11):1271-80. PubMed ID: 9532233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
